Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Elder Pharmaceuticals has entered into an exclusive manufacturing tie-up with Gelnova Laboratories of Navi Mumbai to introduce nicotine replacement therapy (NRT) products in pastille form.
Subscribe to our email newsletter
Launched under the brand name of Elder NRT, the product is a joint collaborative effort of Elder Pharma’s R&D division and Gelnova.
Pastilles are hard jelly like preparation in cube shape which is a mixture of glycerin and gelatin to which medicament is added. Pastilles release active substance in a finely distributed way that gets absorbed directly into the bloodstream.
Elder Pharmaceuticals said that NRT is used for cessation of cancer-causing habit of tobacco chewing and tobacco smoking. NRTs are engineered to work on the brain and the nervous system to curb nicotine dependence. NRT supplies controlled levels of nicotine that allow one to gradually reduce intake of tobacco.
Elder Pharmaceuticals stated that NRT will be promoted through medical practitioners, chest physicians and dentists.
Alok Saxena, director of Elder Pharmaceuticals, said: “A few years back we were marketing Nulife chewing gums in the same business category belonging to Ceejay Health Care through the ethical route and found the acceptance of NRT products growing in India.
“We estimate the market size for NRT products to be about Rs 720crore of which the prescription based segment should be worth about Rs 200crore and the balance comprising of non-prescription, OTC (Over the Counter) products which are also sold through unorganised sales channels like paan shops.”